Glyscend
Latest round
- Series A
Last raised
- Jun 2020
Total raised
- $21M
Investors
- 3
About Glyscend
Glyscend, Inc.Founded in 2014, Glyscend, Inc. is based in Baltimore, US, specializing in solutions for type 2 diabetes and obesity. The company was co-founded by Ashish Nimgaonkar and Thomas Jozefiak.Glyscend, Inc. specializes in developing innovative therapeutic solutions aimed at treating type 2 diabetes and managing weight for overweight and obese patients. The company's core product offerings are based on a polymer therapeutic platform designed to mimic the physiological effects of bariatric surgery without the need for invasive procedures. These orally administered drugs aim to replicate the benefits of gastric bypass surgery and duodenal exclusion devices, helping to manage glucose levels and support weight loss in patients. Glyscend targets various geographical markets, including the United States and potentially other regions with a significant population of individuals affected by type 2 diabetes and obesity.Glyscend's revenue model revolves around partnerships and collaborations with healthcare providers and pharmaceutical distribution channels. The company engages in B2B transactions, supplying its oral therapeutic products to healthcare systems and institutions that cater to diabetes and obesity management. The structured transactions involve direct sales agreements or collaborative arrangements with healthcare organizations, ensuring the products reach the end-users effectively.5 mn in June 2020, Glyscend, Inc. plans to advance the development of its therapeutic solutions. The company aims to expand its market presence, focusing on the United States and evaluating opportunities in additional regions with high diabetic and obese populations.
Who invested in Glyscend
3 investors across 2 rounds
See all investors in Glyscend
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Glyscend
Who invested in Glyscend?
Glyscend has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Glyscend raised?
Glyscend has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Glyscend last raise money?
Glyscend's most recent round on record is a Series A, in Jun 2020.
What does Glyscend do?
Glyscend is a biotechnology company.
Where is Glyscend headquartered?
Glyscend is headquartered in Baltimore, US.
Which VCs invest in companies like Glyscend?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Glyscend's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Glyscend? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.